Back to VANGUARD GROUP INC VANGUARD GROUP INC

LGNDLGND
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in LIGAND PHARMACEUTICALS

VANGUARD GROUP INC holds 2.1M shares of LGND (LIGAND PHARMACEUTICALS), worth $392.1M as of 2025-Q4. The position was decreased (-0.1% shares). LGND represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$392.1M

Current Shares

2.1M

Total Value Change

+$194.9M

Total Shares Change

+103,270

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Decreased
2.1M
-0.1%
$392.1M0.0%$190.20
0
2025-Q3
Decreased
2.1M
-0.6%
$367.8M0.0%$173.13
0
2025-Q2
Increased
2.1M
+1.6%
$237.5M0.0%$114.15
31
2025-Q1
Decreased
2.1M
-1.4%
$216.1M0.0%$107.62
0
2024-Q4
Increased
2.1M
+5.8%
$223.5M0.0%$105.76
32
2024-Q3
New
2M
-
$197.2M0.0%$97.37
42

Other major holders of LGND: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used